U.S. market Open. Closes in 1 hour 45 minutes

BBC | Virtus LifeSci Biotech Clinical Trials ETF Overview

(Stock Exchange: AMEX)
Day's Range 17.31 - 17.71
52 Week Range 17.29 - 31.65
Beta 1.04
Implied Volatility 27.38%
IV Rank 74.15%
Day's Volume 262,802
Average Volume 20,081
Shares Outstanding 325,859
Inception Date 2014-12-17
Assets 10,385,303
Asset Class Equity
Expense Ratio 0.79
P/E Ratio N/A
EPS N/A
Dividend Yield 1.45%
Dividend Per Share 0.25
Dividend ExDate N/A
Dividend PayDate N/A
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
*Chart delayed
Watching at BBC technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on BBC Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙